Agios to Present at Canaccord Genuity 36th Annual Growth Conference Wednesday, August 10, 2016
CAMBRIDGE, Mass., Aug. 05, 2016 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced that the company is scheduled to present at the Canaccord …